• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

OMRF is an independent, nonprofit biomedical research institute dedicated to discoveries that make a difference.

  • About
    • General Information
    • Disease Research
    • Education & Outreach
    • Events
    • Careers
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • News Releases
    • Publications
    • On Your Health
    • Bodywork
  • Patients
    • Anti-Aging Studies
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Disease
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Tax Credit
    • Planned Giving
    • Vehicle Donations
    • Why We Give
    • Your Gift at Work
    • Donor Recognition
    • Contact
Home - OMRF News - Archives for Adakveo

Adakveo

OMRF receives top award from Oklahoma Venture Forum

May 19, 2022

Nonprofit foundation lauded for economic impact in Oklahoma

Filed Under: News Tagged With: Adakveo, andy weyrich, Ceprotin, Dr. Andrew S. Weyrich, Oklahoma Venture Forum, OVF, Soliris

Research on the Rise

In 2011, OMRF completed the largest campus expansion in the foundation’s history. With the construction of a new research tower, OMRF added 186,000 square feet of research and clinical space to its research campus. Funded through a combination of private gifts and state and federal grants, the facility houses dozens of laboratories, an imaging and […]

In Her Blood

Danielle Jamison lived her entire life with the crippling of sickle cell disease, until a groundbreaking drug born at OMRF brought her relief.

A Sickle Cell Milestone

New drug with OMRF roots reduces pain in sickle cell disease.

FDA approves new sickle cell drug with Oklahoma roots

November 18, 2019

Adakveo significantly reduces pain crises in sickle cell patients.

Filed Under: News, Technology Ventures News Tagged With: Adakveo, FDA, FDA approval, McEver, novartis, P-selectin, pain crises, rodger, Rodger McEver, scd, scientist-news, selexys, sickle cell, sickle cell disease

Before Footer

EEO/AA Employer/Vet/Disabled

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Intranet
Facebook Twitter Instagram Linkedin

Subscribe to OMRF News
  • Contact
  • Careers
  • Donor Privacy
  • Intranet
OMRF Logo
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13th St.
Oklahoma City, OK 73104
(405) 271-6673
Charity navigatorUnited WayGive Smart OKCTop Workplace